Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

"Challenging" phenotype of pulmonary arterial hypertension.

Jonas K, Kopeć G.

Pol Arch Intern Med. 2019 Dec 13. doi: 10.20452/pamw.15103. [Epub ahead of print] No abstract available.

2.

Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension.

Jonas K, Waligóra M, Magoń W, Zdrojewski T, Stokwiszewski J, Płazak W, Podolec P, Kopeć G.

Arch Med Sci. 2019 Oct;15(6):1397-1406. doi: 10.5114/aoms.2018.79242. Epub 2018 Oct 25.

3.

HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension.

Jonas K, Kopeć G.

Int J Mol Sci. 2019 Jul 18;20(14). pii: E3514. doi: 10.3390/ijms20143514. Review.

4.

Pulmonary Artery Elastic Properties After Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Magoń W, Stępniewski J, Waligóra M, Jonas K, Podolec P, Kopeć G.

Can J Cardiol. 2019 Apr;35(4):422-429. doi: 10.1016/j.cjca.2019.01.016. Epub 2019 Feb 2.

PMID:
30935632
5.

Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension.

Jonas K, Magoń W, Podolec P, Kopeć G.

Med Sci Monit. 2019 Jan 26;25:746-753. doi: 10.12659/MSM.912766.

6.

Epoprostenol therapy for pulmonary arterial hypertension: the first Polish experience.

Kopeć G, Waligóra M, Jonas K, Stępniewski J, Magoń W, Podolec P.

Pol Arch Intern Med. 2019 Jan 31;129(1):65-68. doi: 10.20452/pamw.4390. Epub 2018 Dec 13. No abstract available.

7.

High‑density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension.

Jonas K, Magoń W, Waligóra M, Seweryn M, Podolec P, Kopeć G.

Pol Arch Intern Med. 2018 Aug 31;128(7-8):440-446. doi: 10.20452/pamw.4306. Epub 2018 Jul 27.

8.

Electrocardiogram reading: a randomized study comparing 2 e‑learning methods for medical students.

Kopeć G, Waligóra M, Pacia M, Chmielak W, Stępień A, Janiec S, Magoń W, Jonas K, Podolec P.

Pol Arch Intern Med. 2018 Feb 28;128(2):98-104. doi: 10.20452/pamw.4146. Epub 2017 Nov 7.

9.

Knowledge of rare diseases among health care students – the effect of targeted education

Jonas K, Waligóra M, Hołda M, Sulicka-Grodzicka J, Strach M, Podolec P, Kopeć G.

Przegl Epidemiol. 2017;71(1):80-89.

10.

Mechanism and prognostic role of qR in V1 in patients with pulmonary arterial hypertension.

Waligóra M, Kopeć G, Jonas K, Tyrka A, Sarnecka A, Miszalski-Jamka T, Urbańczyk-Zawadzka M, Podolec P.

J Electrocardiol. 2017 Jul - Aug;50(4):476-483. doi: 10.1016/j.jelectrocard.2017.02.007. Epub 2017 Feb 20.

PMID:
28256215
11.

Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.

Kopeć G, Waligóra M, Tyrka A, Jonas K, Pencina MJ, Zdrojewski T, Moertl D, Stokwiszewski J, Zagożdżon P, Podolec P.

Sci Rep. 2017 Feb 15;7:41650. doi: 10.1038/srep41650.

12.

Effectiveness of single medical advice on emergency phone number knowledge in urban adult population--"Health, Alcohol and Psychosocial Factors in Eastern Europe" substudy.

Kopeć G, Waligóra M, Brózda M, Jonas K, Sarnecka A, Podolec M, Sobień B, Pająk A, Podolec P.

Przegl Epidemiol. 2015;69(3):543-8, 649-52. English, Polish.

Supplemental Content

Loading ...
Support Center